Bosnian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
adenocarcinoma/phosphatase
Veza se sprema u međuspremnik
11 rezultati
FOLFIRI Alternate With FOLFOX in Untreated Metastatic Gastric and Esophageal Adenocarcinoma
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
1. Current Knowledge and Rationale Gastro-esophageal (GE) cancers are a highly aggressive disease and are one of the major causes of cancer-related death in the world. Despite improvements in surgical and radiation techniques and the availability of newer agents, the prognosis of recurrent GE
Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast Cancer
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
This is A Phase III, randomized, two-armed, patient-outcome assessor-data analyzer blinded, parallel active controlled non-Inferiority clinical trial study to evaluate efficacy and safety of AryoTrust (Aryogen Trastuzumab) in comparison to Herceptin® (Genentech/Roche) in patients with Human
Docetaxel Followed by Provenge in Metastatic Prostate Cancer
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Castration-resistant prostate cancer (CRPC) develops serial treatment resistance and is considered incurable. It is a largely indolent disease, which would give the body time to mount an effective immune response. CRPC is therefore potentially well suited for vaccine therapy.
Docetaxel is an
Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Castration-resistant prostate cancer (CRPC) develops serial treatment resistance and is considered incurable. It is a largely indolent disease, which would give the body time to mount an effective immune response. CRPC is therefore potentially well suited for vaccine therapy.
Sipuleucel-T
Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
All subjects will have a baseline CT or FDG-PET/CT prior to initiation of therapy. This will be done at the Hillman or in Radiation Oncology. Enrolled patients will undergo appropriate lab work and staging as described
1. Albumin, alkaline phosphatase, glucose, electrolytes
2. Ca 19-9 and CEA
3. Due
Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal Cancer
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
1. Design: A randomized, controlled, open, parallel group study to assess the survival and disease-free period or progression in patients with advanced CGE over a period of 2 years.
2. Under study: Patients diagnosed in histology for the first time, advanced-stage CGE and fulfilling the inclusion
Selenium in Treating Patients With Prostate Cancer
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
OBJECTIVES:
- To investigate the ability of selenium to prevent progression in patients with adenocarcinoma of the prostate.
- To investigate the ability of selenium to effectively modulate biomarkers of prostate cancer.
- To determine if selenium modifies the progression of prostate cancer based on
Neo-adjuvant Chemotherapy in Locally Advanced Gastric Cancer
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Comparative Study of Laparoscopic Versus Open Operations for Colon Cancer
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
AIMS
The primary aim of the study is to test the hypothesis that tumour related disease free interval and overall survival are equivalent regardless whether patients receive laparoscopic colon resection (LCR) or open colon resection (OCR) at three and five years post operatively. The secondary aims
A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Objectives
Primary
- To assess the safety and tolerability of TroVax injections when given as a therapeutic vaccine to patients with metastatic renal cell cancer
- To assess the immune responses induced by treatment with TroVax
Secondary
- To assess the impact of treatment with TroVax on tumour
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Objectives:
I. Compare the time to progression, time to development of disease-related pain, and incidence of grade 3 or worse treatment-related adverse events in patients with asymptomatic metastatic hormone refractory adenocarcinoma of the prostate treated with APC8015 versus control infusion. II.
Najkompletnija baza ljekovitog bilja potpomognuta naukom
- Radi na 55 jezika
- Biljni lijekovi potpomognuti naukom
- Prepoznavanje biljaka po slici
- Interaktivna GPS karta - označite bilje na lokaciji (uskoro)
- Pročitajte naučne publikacije povezane sa vašom pretragom
- Pretražite ljekovito bilje po učincima
- Organizirajte svoja interesovanja i budite u toku sa istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Sve informacije temelje se na objavljenim naučnim istraživanjima
